22 February 2025 in Molecular Psychiatry
Germline mutations of YY1 cause Gabriele-de Vries syndrome (GADEVS), a neurodevelopmental disorder featuring intellectual disability and a wide range of systemic manifestations. To dissect the cellular and molecular mechanisms underlying GADEVS, we combined large-scale imaging, single-cell multiomics and gene regulatory network reconstruction in 2D and 3D patient-derived physiopathologically relevant cell lineages. YY1 haploinsufficiency causes a pervasive alteration of cell type specific transcriptional networks, disrupting corticogenesis at the level of neural progenitors and terminally differentiated neurons, including cytoarchitectural defects reminiscent of GADEVS clinical features. Transcriptional alterations in neurons propagated to neighboring astrocytes through a major non-cell autonomous pro-inflammatory effect that grounds the rationale for modulatory interventions. Together, neurodevelopmental trajectories, synaptic formation and neuronal-astrocyte cross talk emerged as salient domains of YY1 dosage-dependent vulnerability. Mechanistically, cell type resolved reconstruction of gene regulatory networks uncovered the regulatory interplay between YY1, NEUROG2 and ETV5 and its aberrant rewiring in GADEVS. Our findings underscore the reach of advanced in vitro models in capturing developmental antecedents of clinical features and exposing their underlying mechanisms to guide the search for targeted interventions.
16 February 2024 in bioRxiv
Germline mutations of YY1 cause Gabriele-de Vries syndrome (GADEVS), a neurodevelopmental disorder featuring intellectual disability and a wide range of systemic manifestations. To dissect the cellular and molecular mechanisms underlying GADEVS, we combined large-scale imaging, single-cell multiomics and gene regulatory network reconstruction in 2D and 3D patient-derived physiopathologically relevant cell lineages. YY1 haploinsufficiency causes a pervasive alteration of cell type specific transcriptional networks, disrupting corticogenesis at the level of neural progenitors and terminally differentiated neurons, including cytoarchitectural defects reminiscent of GADEVS clinical features. Transcriptional alterations in neurons propagated to neighboring astrocytes through a major non-cell autonomous pro-inflammatory effect that grounds the rationale for modulatory interventions. Together, neurodevelopmental trajectories, synaptic formation and neuronal-astrocyte cross talk emerged as salient domains of YY1 dosage-dependent vulnerability. Mechanistically, cell-type resolved reconstruction of gene regulatory networks uncovered the regulatory interplay between YY1, NEUROG2 and ETV5 and its aberrant rewiring in GADEVS. Our findings underscore the reach of advanced in vitro models in capturing developmental antecedents of clinical features and exposing their underlying mechanisms to guide the search for targeted interventions.
28 February 2026 in bioRxiv
Background: Transposable elements (TEs) are increasingly recognized as regulators of gene expression and cellular identity in development and disease. Single-cell RNA-sequencing (scRNA-seq) enables the analysis of their transcription at cellular resolution, but the repetitive nature of TEs and their frequent overlap with genes create substantial mapping ambiguity. Although several tools quantify TE expression, few support locus-specific analysis, and their performance in single-cell data has not been systematically evaluated. Results: We present a comprehensive benchmarking framework for locus-level TE quantification in short-read scRNA-seq, combining real datasets with simulations that provide read-level ground truth. TE-derived reads constitute a considerable fraction of the transcriptome and capture meaningful biological structure. Our simulations reveal that older, sequence-diverged insertions can be quantified with relatively high accuracy, whereas young TEs remain intrinsically difficult to resolve due to unreliable assignment of multi-mapping reads. We observe pronounced family-specific biases and identify gene-TE disambiguation as a major unresolved challenge. Among evaluated methods, SoloTE (unique-mapper mode) and Stellarscope (with an expectation-maximization-based reallocation of multi-mappers) showed comparable performance, while including multi-mappers generally increased false positives without substantially improving locus-level accuracy. Conclusions: Our benchmark delineates the fundamental limits imposed by short-read scRNA-seq on locus-specific TE quantification, providing practical guidance for prospective users. Suggested best practices include focusing locus-level analyses on older insertions, applying unique-mapper strategies to improve precision, aggregating counts at the subfamily level for young TEs, and explicitly checking for gene-TE overlaps. Our workflow is fully reproducible and extensible, providing a foundation for evaluating emerging methods aimed at resolving TE transcription at single-locus resolution.